Elizabeth Holmes' partner, Billy Evans, has launched a new AI-powered biotech startup, Haemanthus, focused on developing affordable medical testing technology using Raman spectroscopy. The company, employing former Luminar Technologies colleagues, has secured funding from friends and family. While Holmes, currently serving an 11-year prison sentence for Theranos fraud, is advising Evans, she's not taking a formal role in Haemanthus. The startup aims to commercialize the technology, currently used in research settings to diagnose diseases like ALS and cancer, making it accessible for widespread use.
Prepared by Christopher Adams and reviewed by editorial team.
Comments